Patents Assigned to SELONTERRA, INC.
  • TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20230348978
    Abstract: The present invention provides compositions and methods using certain GPR4-regulated genes and expression products thereof (namely YAP1, CTGF, CCND3, BDNF, VCL, ITGB3) for diagnosis, treatment and prevention of Alzheimer's disease and Mild Cognitive Impairment. The present invention also relates to a method of identifying therapeutic agents to treat and diagnose Alzheimer's disease or Mild Cognitive Impairment based on the differential expression of GPR4-regulated genes.
    Type: Application
    Filed: January 7, 2021
    Publication date: November 2, 2023
    Applicant: SELONTERRA, INC.
    Inventors: Anne URFER-BUCHWALDER, Roman Urfer
  • USE OF SNCA-MEDIATED GENES FOR DIAGNOSIS AND TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20220325346
    Abstract: The present invention provides compositions and methods using SNCA-mediated genes and expression products thereof for diagnosis, treatment and prevention of Parkinson's disease. The present invention also relates to a method of identifying therapeutic agents to treat and diagnose Parkinson's disease based on SNCA-mediated genes.
    Type: Application
    Filed: July 9, 2020
    Publication date: October 13, 2022
    Applicant: SELONTERRA, INC.
    Inventors: ANNE URFER-BUCHWALDER, ROMAN URFER